CN105341946A - Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule - Google Patents
Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule Download PDFInfo
- Publication number
- CN105341946A CN105341946A CN201510930849.3A CN201510930849A CN105341946A CN 105341946 A CN105341946 A CN 105341946A CN 201510930849 A CN201510930849 A CN 201510930849A CN 105341946 A CN105341946 A CN 105341946A
- Authority
- CN
- China
- Prior art keywords
- lutein
- soft capsule
- algae
- cowberry
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012680 lutein Nutrition 0.000 title claims abstract description 81
- 239000001656 lutein Substances 0.000 title claims abstract description 81
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 81
- 229960005375 lutein Drugs 0.000 title claims abstract description 81
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 81
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 81
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 80
- 239000007901 soft capsule Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 241000195633 Dunaliella salina Species 0.000 title abstract 4
- 241000609610 Gaylussacia Species 0.000 title abstract 4
- 235000004101 Gaylussacia dumosa Nutrition 0.000 title abstract 4
- 235000013871 bee wax Nutrition 0.000 claims abstract description 27
- 241000195493 Cryptophyta Species 0.000 claims description 80
- 150000003839 salts Chemical class 0.000 claims description 49
- 235000016357 Mirtillo rosso Nutrition 0.000 claims description 41
- 244000077923 Vaccinium vitis idaea Species 0.000 claims description 41
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims description 41
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 32
- 235000013399 edible fruits Nutrition 0.000 claims description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000012166 beeswax Substances 0.000 claims description 26
- 239000003292 glue Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 15
- 108010010803 Gelatin Proteins 0.000 claims description 15
- 244000299461 Theobroma cacao Species 0.000 claims description 15
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 15
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 15
- 235000001046 cacaotero Nutrition 0.000 claims description 15
- 229920000159 gelatin Polymers 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 15
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 239000000049 pigment Substances 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 15
- 239000004408 titanium dioxide Substances 0.000 claims description 15
- 235000010215 titanium dioxide Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 14
- 235000013734 beta-carotene Nutrition 0.000 claims description 14
- 239000011648 beta-carotene Substances 0.000 claims description 14
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 14
- 229960002747 betacarotene Drugs 0.000 claims description 14
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000001993 wax Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 6
- -1 limit edged stirs Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 3
- 239000004519 grease Substances 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 238000004513 sizing Methods 0.000 claims description 3
- 229930014669 anthocyanidin Natural products 0.000 claims description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims description 2
- 235000008758 anthocyanidins Nutrition 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 208000003464 asthenopia Diseases 0.000 abstract description 17
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 5
- 239000008169 grapeseed oil Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 22
- 238000012360 testing method Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 11
- 235000006708 antioxidants Nutrition 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000004438 eyesight Effects 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 230000004310 photopic vision Effects 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 208000027993 eye symptom Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000015612 Complement 3b Receptors Human genes 0.000 description 1
- 108010024114 Complement 3b Receptors Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000003532 cataractogenesis Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 208000019064 esophageal ulcer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 125000002635 lutein group Chemical group 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000002577 ophthalmoscopy Methods 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000005985 stomach dysfunction Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a dunaliella salina, lutein and huckleberry composition and a preparation method thereof. The composition is prepared from dunaliella salina extractive, lutein, huckleberry extractive, beewax and the balance of grape seed oil, and has remarkable antioxidation and the function of relieving visual fatigue. The invention also provides a soft capsule preparation containing the dunaliella salina, lutein and huckleberry composition and a preparation method of the soft capsule preparation.
Description
Technical field
The present invention relates to the technical field of health product, especially a kind of salt algae lutein cowberry composition, comprises soft capsule preparation and the preparation method of said composition.
Background technology
Along with the quickening of modern people's life, study, work rhythm, universal and the application of TV, computer, and the impact that natural environment goes from bad to worse, asthenopia has become one of common eye disease, have and report in the experimenter carrying out conventional ophthalmic inspection, to have the people of 10%-to 15% owing to producing headache and visual fatigue because working before computer, and this phenomenon there is the trend of growth.Cause white elephant to eyes before the fluorescent screen that eyes are exposed to flicker for a long time, cause visual fatigue, impel retinal ocular disease and some chronic ocular disease to fall ill to shift to an earlier date and illness rate raises.The eye syndrome of visual fatigue to be a kind of with subjective symptoms be main clinical manifestation, asthenopic generation is the result that eye or whole body apparatus factors and psychologic factors are intertwined to form.Headache, dizzy, spasm of ocular muscles can be produced under visual fatigue serious conditions, bring out stomach dysfunction, the symptom such as whole body is uncomfortable.
The product of alleviating asthenopia is mostly exterior-applied article in the market, can not fundamentally prevent and improve asthenopia.So need to develop a kind of health food having protective effect for eyesight.
Summary of the invention
According to an aspect of the present invention, an object of the present invention is to provide a kind of salt algae lutein cowberry composition, said composition has remarkable non-oxidizability and asthenopia releasing function.
In order to achieve the above object, the invention provides following technical scheme: a kind of salt algae lutein cowberry composition, described composition comprises according to weight ratio: the grape-kernel oil of algae extrats 4%-10%, lutein 1.5%-4%, Bilberry fruit P.E 4-10%, beeswax 3%-5% and surplus.
Preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: the grape-kernel oil of algae extrats 4%-6%, lutein 1.5%-3%, Bilberry fruit P.E 4-6%, beeswax 4%-5% and surplus.
More preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: 4%, the algae extrats of 5% or 6%, 1.5%, the lutein of 2%, 2.5% or 3%, the Bilberry fruit P.E of 4%, 5% or 6%, the beeswax of 4%-5% and the grape-kernel oil of surplus.
Further preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: algae extrats 6%, and lutein 3%, Bilberry fruit P.E is 6%, beeswax 4% and grape-kernel oil 81%.
Further preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: algae extrats 4%, and lutein 1.5%, Bilberry fruit P.E is 4%, beeswax 4% and grape-kernel oil 86.5%.
Further preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: algae extrats 5%, and lutein 2%, Bilberry fruit P.E is 4%, beeswax 5% and grape-kernel oil 84%.
Further preferably, salt algae lutein cowberry composition according to the present invention comprises according to weight ratio: algae extrats 6%, and lutein 2.5%, Bilberry fruit P.E is 6%, beeswax 4.5% and grape-kernel oil 81%.
In algae extrats described in described composition, the weight percentage of beta carotene is 8%.
In Bilberry fruit P.E described in described composition, anthocyanidin weight percentage is 25%.
According to another aspect of the present invention, an object of the present invention is to provide the soft capsule preparation comprising described salt algae lutein cowberry composition, described soft capsule preparation is made up of content and soft capsule shell, described content is above-mentioned salt algae lutein cowberry composition, and described soft capsule comprises the purified water of gelatin 25%-40%, glycerine 10%-17%, D-sorbite 5%-8%, titanium dioxide 1.5%-3%, Cacao pigment 1.5%-3% and surplus according to weight ratio.
Preferably, each raw material of described soft capsule shell according to weight ratio is: gelatin 40%, glycerine 12%, D-sorbite 5%, titanium dioxide 0.5%, Cacao pigment 2.5% and purified water 40%.
According to another aspect of the present invention, another object of the present invention is to provide the preparation method of described salt algae lutein cowberry soft capsule preparation, said method comprising the steps of:
1) salt algae lutein cowberry composition feed liquid (content feed liquid) is prepared:
Weigh algae extrats, Bilberry fruit P.E, lutein, beeswax, grape-kernel oil respectively, for subsequent use; After grape-kernel oil and beeswax heating for dissolving, obtain oily wax liquid; When oily wax liquid is cooled to room temperature, algae extrats, Bilberry fruit P.E, lutein are joined in oily wax liquid, limit edged stirs, mix, then be placed in colloid mill and grind 3-5 time, vacuumize, vacuum remains on-0.06 ~-0.08Mpa with de-bubble to the greatest extent, cross 120 mesh sieves, obtain content feed liquid, stand-by.
2) glue is prepared: weigh gelatin, glycerine, titanium dioxide, D-sorbite, cacao pigment, purified water respectively, for subsequent use; By in glycerine, titanium dioxide, cacao pigment, D-sorbite and putting into of purified water glue tank, stir, when being heated to 70 ~ 80 DEG C, add gelatin, stir and boil 1h, vacuumize, de-bubble to the greatest extent, crosses 80 mesh sieves, make glue, put into glue bucket insulation (60 DEG C ~ 65 DEG C), for subsequent use.
3) capsule is pressed into: the tolerant feed liquid of Inner, glue, by pellet press, make soft capsule.In pelleting process, check a ball weight, guarantee that content uniformity is in acceptability limit, checks capsule appearance at any time every about 30min, whether ball shape is normal, has ne-leakage.In production process, keep a close eye on the working order of equipment, temperature remains on 18 ~ 26 DEG C, and relative humidity is 40% ± 5%.
4) shape: the soft capsule be pressed into is placed in sizing rotating cage and shapes about 1 ~ 2.5 hour, and temperature remains on 18 ~ 26 DEG C, relative humidity 40% ± 5%.
5) dry: the soft capsule after heat treatment 18 ~ 26 DEG C temperature and 30% ± 5% relative humidity under carry out preliminarily dried about 16 hours.
6) ball is washed: dried soft capsule is put in ultrasonic wave soft capsule cleaner with the 95% edible alcohol cleaning meeting GB10343 quality requirement, the grease on removing surface, the temperature of 18 ~ 26 DEG C and 30% ± 5% relative humidity under, the soft capsule after cleaning is divided in screen tray, for subsequent use.
7) dry in the air ball: the soft capsule after cleaning is divided in drying cart screen tray, and send into drying room and carry out drying, temperature remains on 18 ~ 26 DEG C, relative humidity 30% ± 5%.
Preferably, the preparation method of described salt algae lutein cowberry soft capsule preparation also comprises 8) packaging:
By step 7) in the salt algae lutein cowberry soft capsule that obtains screen, remove the defective soft capsule such as large piller, special-shaped ball, flat ball, the ball that breaks, thin-walled ball, significantly wire mark ball, bubble ball, adhesion ball, the capsule meeting finished product requirement is wrapped inside dress, be encapsulated in medicinal high density ethylene bottle, then after check problem, be divided into marketing packing namely become the finished product that can dispatch from the factory.
Accompanying drawing explanation
In order to be illustrated more clearly in the embodiment of the present invention or technical scheme of the prior art, be briefly described to the accompanying drawing used required in embodiment or description of the prior art below, apparently, accompanying drawing in the following describes is only some embodiments of the present invention, for those of ordinary skill in the art, under the prerequisite not paying creative work, other accompanying drawing can also be obtained according to these accompanying drawings.
Fig. 1 is the flow chart of preparation method of the present invention.
Detailed description of the invention
Below in conjunction with accompanying drawing of the present invention, be clearly and completely described technical scheme of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Salt algae is a kind of single celled eukaryotic algae, it is one of eucaryote of the most salt tolerant found up to now, salt algae is throughout the year not only high temperature resistant but also resist cold, containing protein up to about 50% (dry powder extracted after carrotene reaches more than 70%), and be rich in the beta carotene with unique health care and medical effect.Content beta-carotene contained by it is higher than carrot to 60-160 times.The same with other natural materials, algae carrotene has the broad-spectrum action of carrotene, the medical health care function of salt algae beta carotene is affirmed: anti-oxidant, binding activities oxygen, catch free radical, radioresistance and photosensitization damage, raising immunity, anti-sudden change, antitumor and can change into the effects such as vitamin A, preventing and treating the cancer of more than belly, yctalopia and cataract, cardiovascular disease, oral cavity, esophagus and gastric ulcer, chemotherapy patients, old age and valetudinarian have good therapeutic effect.Beta carotene is the ideal medicament of anti-curing cancers, cardiovascular disease, chemotherapy patients, vitamine A deficiency.It is degraded by body metabolism, use safety, and this is that other cancer therapy drugs institute can not be than.With the functional health care product that salt algae produces, there is extra-nutritions, remove oxyradical, delay senility, raising immunity and to functions such as the resistivities of disease.
Experiment shows: algae extrats obviously can reduce LPO content in blood and liver, improves SOD and GSH-Px active, have anti-oxidant, delay senility left and right.Epidemiological study shows: in body, the incidence of beta carotene and vitamin a level and tumour is negative correlation.And have research surface: relevant with cancer metastasis under the anti-oxidation function of tumor patient.Long-term taking salt algae will improve the anti-oxidation function of body, thus suppresses recurrence and the transfer of cancer, and anti-oxidation function and the immunologic function of body are closely related, because free radical causes immunosupress.And beta carotene has enhancing immunity of organism and oxidation resistant effect.Therefore, can promote body killing and wounding tumour cell, its effect is extensive, nontoxic, and abundance, has positive effect to the prevention and therapy of malignant tumour.
Salt algae beta carotene has the non-specific humoral and cellular immune response function of promotion, particularly evident to the effect of T lymphopoiesis and t lymphocyte subgroup.Beta carotene facedown lipid peroxidation of erythrocyte membrane is damaged, and alleviates the destruction of C3b receptor, improves its activity, adds the immune adherence to tumour cell and lethal effect.
Salt algae beta carotene, as antioxidant, has anti peroxidation of lipid lesion capability, and reduce Serum MDA, (MDA) reduces the content of Arterial Cholesterol (TC) cholesteryl ester (CE) and MDA.There is protective effect to endarterium and stop its foamed, the generation of effective prevention of arterial sclerosis pathology and development, and in dose-dependence.To be that clinical practice antioxidant prevention of arterial is atherosis provide theoretical foundation in this research.There are some researches show: lipid-metabolism wadding disorderly, on the basis of radical damage and artery sclerosis correlation, for the sclerosis generation of pathology of beta carotene prevention of arterial and development provide test basis, prove the oral effect with prevention of arterial sclerosis of beta carotene, support the neodoxy of antioxidant prevention coronary heart disease.Atherosclerotic is the pathologic basis of cardiovascular and cerebrovascular disease.It occurs, develop and fat metabolism is wadded a quilt with cotton disorderly in close relations, particularly closely related with the deposition of oxidized low density lipoprotein, beta carotene is fat-soluble antioxidant in human body, mainly act on MDA, suppress the peroxidating of unrighted acid on membranous structure.
Lutein has another name called " Lutein ", is a kind of natural colouring matter be extensively present in the plants such as banana, Kiwi berry, corn and marigold.Lutein belongs to the one of carotenoid.This natural colouring matter has the advantages such as lovely luster, strong coloring force, safety non-toxic, oxidation resistance be strong.
Lutein is the precursor of vitamin A, and it can change into vitamin A in human body.The main Physiological Function of lutein to eyes is as antioxidant and photoprotection.Optic nerve is unrenewable, and what be vulnerable to oxidative damage most is bar, the cone cell that on retina, content of polyunsaturated fatty acid is higher, by the formation suppressing oxygen radical to suppress harmful free radicals.The a large amount of blue light of lutein Absorbable rod, wavelength and the ultraviolet light of blue visible light are close, are to reach the maximum a kind of light of potential hazard in amphiblestroid visible ray.Before arriving cell responsive on retina, light first through the highest accumulation regions of lutein, if at this moment just this injury can be reduced to minimum depending on the lutein content at macula lutea place is abundant.
Bilberry fruit P.E demonstrates the obvious help of eye by improving oxygen and blood-transmitted to the ability of eye.The source that many eye diseases comprise Cataractogenesis and macular degeneration finally ascribes the injury of radical pair eye to.Bilberry fruit P.E, as strong antioxidant, can protect eyes from free radical injury.Scientific research display Healthy People uses Bilberry fruit P.E can cause the improvement of night vision acuity, the raising of the quickening of blackout governing speed and the rear eyesight resume speed of flash of light.
Grape-kernel oil is the natural product refined by grape pip expression separation and obtain.In various animal and plant oil known at present, essential fatty acid contained in grape-kernel oil is the highest (>90%), and wherein linoleic content reaches more than 75%.Also containing liposoluble vitamin and various trace elements such as abundant vitamin E and a certain amount of vitamin A, D in grape-kernel oil.Therefore, grape-kernel oil is a kind of rare natural product.Grape pip crude oil is light green color, is colourless or oyster after refining, smell without exception, and not containing cholesterol and sodium, its Heat stability is good, smoke point is high.Its nutritive value and medical function all obtain the abundant affirmation of domestic and international medical circle and nutrition man; there is reduction blood fat, softening blood vessel, prevention vascular sclerosis, reduce blood pressure, reduce blood viscosity and prevent the various biological effectiveness such as thrombosis; also can produce, maintain the function of epithelium and nerve cell normal configuration and anti-oxidant, anti-ageing, the various physiological action such as vision protection, promotion upgrowth and development of children; grape-kernel oil is suitable for various different crowd, is particularly suitable for the elderly edible.
The present invention is the mode adopting oral soft capsule preparation, fundamentally increases eye nutrition, reaches the object alleviated and repair.Its algae extrats Wheat Protein, can nutrition human body cell, effectively alleviates or eliminates visual fatigue; Lutein is enrichment on the retina, can improve GJIC function, maintains amphiblestroid normal vision, and protection retina damages from blue light, suppression, cancellation free radical; Bilberry fruit P.E, as strong antioxidant, can protect eyes from free radical injury.Algae extrats, lutein and Bilberry fruit P.E all belong to integration of drinking and medicinal herbs, take safe and reliable, and three's Synergistic has very strong antioxidation activity, and is easily absorbed by the body, and energy is scavenging free radicals in time, keep eye vigor.For mid-aged population with through conventional eye, the crowd of visual fatigue has the function of good alleviation visual fatigue.
Various compositions in salt algae lutein cowberry composition according to the present invention are commercially, such as described algae extrats, lutein, Bilberry fruit P.E can be not gloomy purchased from Shaanxi, described beeswax can purchased from Beijing Procaine Preparations, and described grape-kernel oil can purchased from Hebei Xin Qi Dian Biotechnology Co., Ltd..
Embodiment 1
To make 1000 salt algae lutein cowberry soft capsule preparations for sample.
Formulation selection:
Capsule 's content: take formula material according to weight, gets the algae extrats 30 grams that purity is 8%, and purity is 15 grams, the lutein of 75%, and purity is the Bilberry fruit P.E 30 grams of 25%, 20 grams, beeswax, grape-kernel oil 405 grams.
Soft capsule shell: take formula material according to weight, gets 200 grams, gelatin, glycerine 57 grams, D-sorbite 23 grams, titanium dioxide 0.6 gram, Cacao pigment 2 grams, purified water 200 grams.
The salt algae lutein cowberry soft capsule preparation made according to above-mentioned formula, the tolerant content of every intragranular is 0.5 gram, experimentally proves, according to adult body weight 60KG meter, adult daily once, each one can reach anti-oxidant, alleviates the effect of visual fatigue.
According to Fig. 1, salt algae lutein cowberry soft capsule preparation can be prepared by the method comprising following key step:
1) content feed liquid is prepared:
Weigh algae extrats, Bilberry fruit P.E, lutein, grape-kernel oil, beeswax respectively, for subsequent use; After grape-kernel oil and beeswax heating for dissolving, obtain oily wax liquid; When oily wax liquid is cooled to room temperature, join in oily wax liquid by algae extrats, Bilberry fruit P.E, lutein, limit edged stirs, and mixes, put in colloid mill again and grind 4 times, vacuumize, vacuum remains on-0.06Mpa with de-bubble to the greatest extent, cross 120 mesh sieves, obtain content feed liquid, stand-by.
2) glue is prepared:
Weigh gelatin, glycerine, titanium dioxide, D-sorbite, cacao pigment, purified water respectively, for subsequent use; By in glycerine, titanium dioxide, cacao pigment, D-sorbite and putting into of purified water glue tank, stir, when being heated to 80 DEG C, add gelatin, stir and boil 1h, vacuumize, de-bubble to the greatest extent, crosses 80 mesh sieves, make glue, put into glue bucket insulation (60 DEG C ~ 65 DEG C), for subsequent use.
3) capsule is pressed into:
The tolerant feed liquid of Inner, glue, by pellet press, make soft capsule.In pelleting process, check a ball weight, guarantee that content uniformity is in acceptability limit, checks capsule appearance at any time every about 30min, whether ball shape is normal, has ne-leakage.In production process, keep a close eye on the working order of equipment.Temperature remains on 18 ~ 26 DEG C, and relative humidity is 40% ± 5%.
4) shape:
The soft capsule be pressed into is put in sizing rotating cage and is shaped 1 hour, and temperature remains on 18 ~ 26 DEG C, and relative humidity is 40% ± 5%.
5) dry:
Soft capsule after heat treatment 18 ~ 26 DEG C temperature and 30% ± 5% relative humidity under carry out preliminarily dried about 16 hours.
6) ball is washed:
Dried soft capsule is put in ultrasonic wave soft capsule cleaner with the 95% edible alcohol cleaning meeting GB10343 quality requirement, the grease on removing surface, the temperature of 18 ~ 26 DEG C and 30% ± 5% relative humidity under, the soft capsule after cleaning is divided in screen tray, for subsequent use.
7) dry in the air ball:
Soft capsule after cleaning is divided in drying cart screen tray, sends into drying room and carries out drying, temperature (18 ~ 26) DEG C, relative humidity 30% ± 5%.
8) pack:
By step 7) in the salt algae lutein cowberry soft capsule preparation that obtains screen, remove the defective soft capsule such as large piller, special-shaped ball, flat ball, the ball that breaks, thin-walled ball, significantly wire mark ball, bubble ball, adhesion ball, the capsule meeting finished product requirement is wrapped inside dress, be encapsulated in medicinal high density ethylene bottle, then after check problem, be divided into marketing packing namely become the finished product that can dispatch from the factory.
Embodiment 2
Except preparing except capsule 's content and glue respectively according to following proportioning, salt algae lutein cowberry soft capsule preparation is prepared according to the method that embodiment 1 is similar, wherein algae extrats 20 grams, 7.5 grams, lutein, Bilberry fruit P.E 20 grams, 20 grams, beeswax, grape-kernel oil 432.5 grams, described glue comprises 200 grams, gelatin, glycerine 57 grams, D-sorbite 23 grams, titanium dioxide 0.6 gram, Cacao pigment 2 grams, purified water 200 grams.
Embodiment 3
Except preparing except capsule 's content and glue respectively according to following proportioning, salt algae lutein cowberry soft capsule preparation is prepared according to the method that embodiment 1 is similar, algae extrats 25 grams, 10 grams, lutein, Bilberry fruit P.E 20 grams, 25 grams, beeswax, grape-kernel oil 420 grams, described glue comprises 200 grams, gelatin, glycerine 57 grams, D-sorbite 23 grams, titanium dioxide 0.6 gram, Cacao pigment 2 grams, purified water 200 grams.
Embodiment 4
Except preparing except capsule 's content and glue respectively according to following proportioning, salt algae lutein cowberry soft capsule preparation is prepared according to the method that embodiment 1 is similar, algae extrats 30 grams, 12.5 grams, lutein, Bilberry fruit P.E 30 grams, 22.5 grams, beeswax, grape-kernel oil 405 grams, described glue comprises 200 grams, gelatin, glycerine 57 grams, D-sorbite 23 grams, titanium dioxide 0.6 gram, Cacao pigment 2 grams, purified water 200 grams.
Test example 1
The salt algae lutein cowberry soft capsule preparation obtained with embodiment 1 and embodiment 2 below carries out human experimentation, further illustrates effect that the present invention has alleviating asthenopia.
1) object and method:
Tested material: the salt algae lutein cowberry soft capsule preparation obtained with embodiment 1 and embodiment 2 is for given the test agent.Reference substance soft capsule preparation is made up of content and soft capsule shell, the each raw material of content is lutein 4% according to weight ratio, beeswax 6% and grape-kernel oil 80%, the each raw material of soft capsule shell according to weight ratio is: gelatin 40%, glycerine 12%, D-sorbite 5%, titanium dioxide 0.5%, Cacao pigment 2.5% and purified water 40%.
Study subject: select the personnel participating in test from entering one's name voluntarily the age be 19-23 year, be experimenter with eye, eyesight fatiguability person for a long time, two test group 60 examples, control group 30 are routine.
Diagnostic criteria: use eye for a long time, has that ophthalmodynia, eye are dry, eye is puckery, eye is swollen, blurred vision symptom.
The person's of including in standard: all ages are 19-23 year, being volunteer for a long time, all can carrying out test-meal experiment through being up to the standards with eye, eyesight fatiguability person.
Eliminator's standard: age those who do not meet, gestation or women breast-feeding their children, to this health food allergy sufferers; Be associated with the severe primary diseases such as conscience kidney and hemopoietic system, mental patient; Do not meet inclusive criteria, not by regulation test food, effect or data not umbra sound effect or analysis person cannot be judged.
Contrast form: adopt self cross-reference form.
Taking dose and time: tested material and placebo are each 1, every day 2 times, continuous 30 days, experimenter cut out about the medicine of alleviating asthenopia or other health foods and eyedrops at experimental session.
Instrument and reagent: Olympus fully-automatic analyzer.
2) observation index: be divided into safety indexes and its functional attributes, indices in test-meal on-test and at the end of each to measure once.
2.1) both effectiveness observation: efficiency index criterion
Symptom is improved: ophthalmodynia, eye are dry, eye is puckery, eye is swollen, the arbitrary symptom of blurred vision is improved and other symptoms without deterioration;
Effective: symptom is improved and differed >=0.1 before and after duration of photopic vision, and has statistical significance through statistical comparison difference;
Invalid: not reach effective standard.
3) experimental result:
3.1) general status:
Observe visual fatigue experimenter 90 example altogether, the test group male sex 27 example, women 33 example, minimum 19 years old of age, maximum 23 years old, the mean age (21 ± 1) year, the control group male sex 15 example, women 15 example, minimum 19 years old of age, maximum 23 years old, year mean age (21 ± 1).
3.2) safety indexes is observed:
Before and after test-meal to the eye symptom of test group and control group crowd and funduscopy all in normal range (NR).
3.3) distant vision improvement is compared
Test group right and left eyes distant vision all makes moderate progress than before test-meal, and difference has statistical significance (P < 0.05); After control group test-meal, right and left eyes distant vision is not improved with comparing before test-meal, no significant difference (P > 0.05).
Table 1: distant vision improvement is compared
3.4) duration of photopic vision change is compared
Test group 1 duration of photopic vision rises to 0.71 ± 0.08 after test-meal by 0.59 ± 0.07 before test-meal, improve 0.12 ± 0.03, difference has statistical significance (P < 0.05), test group 2 duration of photopic vision rises to 0.70 ± 0.07 after test-meal by 0.61 ± 0.06 before test-meal, improve 0.09 ± 0.03, difference has statistical significance (P < 0.05); After test-meal, test group 1 duration of photopic vision (0.71 ± 0.08) and test group 2 duration of photopic vision (0.61 ± 0.06) compare with (0.63 ± 0.07) after control group test-meal statistical significance (P < 0.05).
Table 2: before and after test-meal, duration of photopic vision change is compared
3.5) symptom improvement is compared
Table 3: before and after test-meal, symptom improvement is compared
As can be seen from Table 3, the eye symptom trying trencherman has clear improvement.
3.6) before and after test-meal, total effective rate compares
The total effectively number of cases of test group 1 is 19 examples, and total effective rate is 63.33%; The total effectively number of cases of test group 2 is 16 examples, and total effective rate is 53.33%; The total effectively number of cases of control group is 5 examples, and total effective rate is 16.67%, and comparing result total effective rate comparing difference has statistical significance (P < 0.05).
Table 4: before and after test-meal, functional observation compares
4) conclusion
According to human experiment result, can think that this health care soft capsule has asthenopia releasing function effect to human body.In whole test-meal process, tested safety indexes all, all in range of normal value, illustrates that taking the health of this product to examination trencherman has no adverse effects.
Claims (9)
1. a salt algae lutein cowberry composition, described composition comprises according to weight ratio: the grape-kernel oil of algae extrats 4%-10%, lutein 1.5%-4%, Bilberry fruit P.E 4-10%, beeswax 3%-5% and surplus.
2. salt algae lutein cowberry composition according to claim 1, it is characterized in that, described salt algae lutein cowberry composition comprises according to weight ratio: the grape-kernel oil of algae extrats 4%-6%, lutein 1.5%-3%, Bilberry fruit P.E 4-6%, beeswax 4%-5% and surplus.
3. salt algae lutein cowberry composition according to claim 1, it is characterized in that, described salt algae lutein cowberry composition comprises according to weight ratio: 4%, the algae extrats of 5% or 6%, 1.5%, the lutein of 2%, 2.5% or 3%, 4%, the Bilberry fruit P.E of 5% or 6%, the beeswax of 4%-5% and the grape-kernel oil of surplus.
4. salt algae lutein cowberry composition according to claim 1, is characterized in that, preferably, described salt algae lutein cowberry composition comprises according to weight ratio: algae extrats 6%, lutein 3%, Bilberry fruit P.E is 6%, beeswax 4% and grape-kernel oil 81%; Or
Preferably, described salt algae lutein cowberry composition comprises according to weight ratio: algae extrats 4%, lutein 1.5%, and Bilberry fruit P.E is 4%, beeswax 4% and grape-kernel oil 86.5%; Or
Preferably, described salt algae lutein cowberry composition comprises according to weight ratio: algae extrats 5%, lutein 2%, and Bilberry fruit P.E is 4%, beeswax 5% and grape-kernel oil 84%; Or
Preferably, described salt algae lutein cowberry composition comprises according to weight ratio: algae extrats 6%, and lutein 2.5%, Bilberry fruit P.E is 6%, beeswax 4.5% and grape-kernel oil 81%.
5. salt algae lutein cowberry composition as claimed in any of claims 1 to 4, it is characterized in that, in described algae extrats, the weight percentage of beta carotene is 8%, and in described Bilberry fruit P.E, anthocyanidin weight percentage is 25%.
6. one kind comprises the soft capsule preparation of salt algae lutein cowberry composition, it is characterized in that, described soft capsule preparation is made up of content and soft capsule shell, described content is salt algae lutein cowberry composition as claimed in any of claims 1 to 5, and described soft capsule comprises the purified water of gelatin 25%-40%, glycerine 10%-17%, D-sorbite 5%-8%, titanium dioxide 1.5%-3%, Cacao pigment 1.5%-3% and surplus according to weight ratio.
7. soft capsule preparation according to claim 6, is characterized in that, each raw material of described soft capsule shell according to weight ratio is: gelatin 40%, glycerine 12%, D-sorbite 5%, titanium dioxide 0.5%, Cacao pigment 2.5% and purified water 40%.
8. a preparation method for soft capsule preparation, said method comprising the steps of:
1) salt algae lutein cowberry composition feed liquid is prepared, i.e. content feed liquid:
Weigh algae extrats, Bilberry fruit P.E, lutein, beeswax, grape-kernel oil respectively, for subsequent use; After grape-kernel oil and beeswax heating for dissolving, obtain oily wax liquid; When oily wax liquid is cooled to room temperature, algae extrats, Bilberry fruit P.E, lutein are joined in oily wax liquid, limit edged stirs, mix, then be placed in colloid mill and grind 3-5 time, vacuumize, vacuum remains on-0.06 ~-0.08Mpa with de-bubble to the greatest extent, cross 120 mesh sieves, obtain content feed liquid, stand-by;
2) glue is prepared: weigh gelatin, glycerine, titanium dioxide, D-sorbite, cacao pigment, purified water respectively, for subsequent use; By in glycerine, titanium dioxide, cacao pigment, D-sorbite and putting into of purified water glue tank, stir, add gelatin when being heated to 70 ~ 80 DEG C, stirring boils, vacuumize, de-bubble to the greatest extent, crosses 80 mesh sieves, make glue, put into 60 DEG C ~ 65 DEG C glue bucket insulations, for subsequent use;
3) capsule is pressed into: the tolerant feed liquid of Inner, glue pass through pellet press, make soft capsule, in pelleting process, check a ball weight every about 30min, guarantee that content uniformity is in acceptability limit, check capsule appearance at any time, whether ball shape is normal, has ne-leakage, in production process, the working order of close attention equipment, temperature remains on 18 ~ 26 DEG C, and relative humidity is 40% ± 5%;
4) shape: the soft capsule be pressed into is placed in sizing rotating cage and shapes about 1 ~ 2.5 hour, and temperature remains on 18 ~ 26 DEG C, relative humidity 40% ± 5%;
5) dry: the soft capsule after heat treatment 18 ~ 26 DEG C temperature and 30% ± 5% relative humidity under carry out preliminarily dried about 16 hours;
6) ball is washed: dried soft capsule is put in ultrasonic wave soft capsule cleaner with the 95% edible alcohol cleaning meeting GB10343 quality requirement, the grease on removing surface, the temperature of 18 ~ 26 DEG C and 30% ± 5% relative humidity under, the soft capsule after cleaning is divided in screen tray, for subsequent use;
7) dry in the air ball: the soft capsule after cleaning is divided in drying cart screen tray, and send into drying room and carry out drying, temperature remains on 18 ~ 26 DEG C, relative humidity 30% ± 5%.
9. the preparation method of soft capsule preparation according to claim 8, is characterized in that, described preparation method also comprises step 8) packaging:
By step 7) in the salt algae lutein cowberry soft capsule that obtains screen, remove the defective soft capsule such as large piller, special-shaped ball, flat ball, the ball that breaks, thin-walled ball, significantly wire mark ball, bubble ball, adhesion ball, the capsule meeting finished product requirement is wrapped inside dress, be encapsulated in medicinal high density ethylene bottle, then after check problem, be divided into marketing packing namely become the finished product that can dispatch from the factory.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510930849.3A CN105341946A (en) | 2015-12-14 | 2015-12-14 | Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510930849.3A CN105341946A (en) | 2015-12-14 | 2015-12-14 | Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105341946A true CN105341946A (en) | 2016-02-24 |
Family
ID=55318224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510930849.3A Pending CN105341946A (en) | 2015-12-14 | 2015-12-14 | Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105341946A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106036600A (en) * | 2016-06-13 | 2016-10-26 | 合肥赛为智慧医疗有限公司 | Dunaliella salina/collagen health product and production method thereof |
CN106912942A (en) * | 2017-03-16 | 2017-07-04 | 哈尔滨紫苏生命科技健康产业有限公司 | Lutein purple perilla method for producing soft capsule |
CN108391816A (en) * | 2017-02-08 | 2018-08-14 | 阙燕娣 | A kind of production method of antioxidant healthcare capsule |
WO2018184125A1 (en) * | 2017-04-04 | 2018-10-11 | Figueroa Lizama Patricio | Preparation method of dehydrating and crushing algae, preferably kelp-type algae (noage marine), which is mixed with a grape seed extract, for food-related, nutritional, dietary and therapeutic purposes |
CN108669555A (en) * | 2018-04-17 | 2018-10-19 | 北京中和鸿业医药科技有限公司 | A kind of Algal Assemblages object, preparation, preparation method and applications |
CN109222086A (en) * | 2018-09-12 | 2019-01-18 | 无限极(中国)有限公司 | A kind of composition and its application and health food with efficacy of relieving visual fatigue |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101283806A (en) * | 2008-04-30 | 2008-10-15 | 黑龙江省嘉宝生物技术开发有限公司 | Diet replenisher containing natural carotenol and its preparation technique |
CN103190610A (en) * | 2013-03-18 | 2013-07-10 | 北京博远欣绿科技有限公司 | Double-pigment soft capsule preparation and preparation method |
CN104382003A (en) * | 2013-08-19 | 2015-03-04 | 宣城柏维力生物工程有限公司 | Xanthophyll and cowberry softgel capsule and preparation method thereof |
-
2015
- 2015-12-14 CN CN201510930849.3A patent/CN105341946A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101283806A (en) * | 2008-04-30 | 2008-10-15 | 黑龙江省嘉宝生物技术开发有限公司 | Diet replenisher containing natural carotenol and its preparation technique |
CN103190610A (en) * | 2013-03-18 | 2013-07-10 | 北京博远欣绿科技有限公司 | Double-pigment soft capsule preparation and preparation method |
CN104382003A (en) * | 2013-08-19 | 2015-03-04 | 宣城柏维力生物工程有限公司 | Xanthophyll and cowberry softgel capsule and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106036600A (en) * | 2016-06-13 | 2016-10-26 | 合肥赛为智慧医疗有限公司 | Dunaliella salina/collagen health product and production method thereof |
CN108391816A (en) * | 2017-02-08 | 2018-08-14 | 阙燕娣 | A kind of production method of antioxidant healthcare capsule |
CN106912942A (en) * | 2017-03-16 | 2017-07-04 | 哈尔滨紫苏生命科技健康产业有限公司 | Lutein purple perilla method for producing soft capsule |
WO2018184125A1 (en) * | 2017-04-04 | 2018-10-11 | Figueroa Lizama Patricio | Preparation method of dehydrating and crushing algae, preferably kelp-type algae (noage marine), which is mixed with a grape seed extract, for food-related, nutritional, dietary and therapeutic purposes |
CN108669555A (en) * | 2018-04-17 | 2018-10-19 | 北京中和鸿业医药科技有限公司 | A kind of Algal Assemblages object, preparation, preparation method and applications |
CN109222086A (en) * | 2018-09-12 | 2019-01-18 | 无限极(中国)有限公司 | A kind of composition and its application and health food with efficacy of relieving visual fatigue |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105341946A (en) | Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule | |
CN102669377B (en) | Lutein ester soft candy and production method thereof | |
CN102578346B (en) | Lutein ester soft sweet and preparation method thereof | |
ES2687657T3 (en) | New nutraceutical compositions and their use | |
CN104839688A (en) | Eye care preparation and preparation method thereof | |
CN104224890B (en) | A kind of xanthophyll soft capsule and preparation method thereof | |
CN108157568A (en) | A kind of Combined candy for alleviating visual fatigue and its preparation method and application | |
US20090297618A1 (en) | Composition beneficial for visuognosis persistence and use thereof | |
JP2010538674A (en) | Nutritional supplements and fortified foods containing such supplements | |
CN106889617A (en) | A kind of eye health-care edible, its preparation method and application | |
CN102283386A (en) | Composite camellia oil health care product with function of reducing blood fat and preparation method thereof | |
CN104474018A (en) | Health-care soft capsule for relieving asthenopia | |
CN101999666A (en) | Health-care product composition for improving vision and preparation method thereof | |
CN109645201A (en) | Composition containing lutein and lutein ester, lutein pressed candy and preparation method and application | |
CN100574772C (en) | A kind of soft capsule that contains phylloxanthin and preparation method thereof | |
CN103190610A (en) | Double-pigment soft capsule preparation and preparation method | |
JP5865242B2 (en) | Composition for treating eye strain | |
CN108041609B (en) | Food composition with functions of relieving visual fatigue and preventing myopia and preparation method thereof | |
CN105030877A (en) | Healthcare food for relieving asthenopia and preparation method thereof | |
JP6336373B2 (en) | Processed food containing marigold extract | |
CN105520137B (en) | It is a kind of that there is the health food alleviated visual fatigue and protect visual function | |
CN106692187A (en) | Composition for improving visuognosis persistence and protecting eye health | |
CN105901577A (en) | Nutritional agent for reinforcing brain, protecting eye and strengthening body and preparation method and application thereof | |
JP2013010714A (en) | Eye fatigue suppressing composition and food and drink including the same | |
CN109731027A (en) | Facilitate the composition and preparation method thereof of alleviation visual fatigue and xerophthalmia series symptom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |
|
RJ01 | Rejection of invention patent application after publication |